My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

14.60 +0.51 (+3.62%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enanta Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Reports Mixed Q4 and Full-Year 2025 Results ↗

November 17, 2025

Enanta Pharmaceuticals reported mixed Q4 2025 results, missing revenue but beating EPS estimates. The biotech firm highlighted strong progress in its RSV and immunology drug pipeline.

Via Chartmill

Earnings Scheduled For November 17, 2025 ↗

November 17, 2025

Via Benzinga

Enanta Pharma's Earnings: A Preview ↗

November 14, 2025

Via Benzinga

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗

November 14, 2025

Via Benzinga

4 Analysts Have This To Say About Enanta Pharma ↗

September 15, 2025

Via Benzinga

The Analyst Verdict: Enanta Pharma In The Eyes Of 4 Experts ↗

February 11, 2025

Via Benzinga

Enanta Pharma Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

December 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 16, 2025

Via Benzinga

Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

Why Ryvyl Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket ↗

October 01, 2025

Via Benzinga

4 Analysts Assess Enanta Pharma: What You Need To Know ↗

November 26, 2024

Via Benzinga

Enanta Pharma Earnings Analysis: Q4 Recap ↗

November 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

September 30, 2025

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

September 29, 2025

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Enanta Pharma Q4 Earnings Assessment ↗

November 25, 2024

Via Benzinga

Insights into Enanta Pharma Q4 Earnings ↗

November 25, 2024

Via Benzinga

Enanta Pharmaceuticals Stock Rises 58% – Here’s An Important Update ↗

September 29, 2025

The company reported that a lower hospitalization rate was observed in patients treated with Zelicapavir compared to those treated with placebo, and the drug demonstrated a robust antiviral effect.

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2025

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults ↗

September 29, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 29, 2025

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44....

Via Benzinga

Top stock movements in today's session. ↗

September 29, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 26, 2025

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

September 26, 2025

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection ↗

June 11, 2025

FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis after positive trial data.

Via Benzinga

Thursday's session: gap up and gap down stocks ↗

February 13, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

United Airlines To Rally More Than 20%? Here Are Top Analyst Forecasts For Monday ↗

December 30, 2024

Via Benzinga

CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 24, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.